Reorganization Answer Now Coming In – Viroloy Extramural Research To Be Under Carcinogenesis
In Brief: Proposed Drug Act Revisions Would Provide Quick Approval Of “Breakthroughs,” IND_NDA Changes
Clearinghouse Insists On New Dichlorvos Test; CSWG Disagrees
ACS Asks Higher NCI Authorization
Six Comprehensive Center Asked By Candlelighters For Pediatric Cancer
AACI Says Fund Reductions Hurt Cancer Centers
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup









